GENECODE DX LIMITED

Incorporated on 30 August 2021 and registered in England and Wales, GENECODE DX LIMITED remains an active private limited company, now trading for 5 years. It changed its name from WONDERWALL CONSULTING LIMITED on 30 August 2021. Its registered office is at 32 Novello Street Novello Street, London, SW6 4JB, England. Its principal activity is other human health activities (SIC 86900).

Dr Andrei Semikhodskii is a person with significant control who holds 25-50% of the shares and voting rights. Mr Simon Green is a person with significant control who holds 25-50% of the shares and voting rights. The board consists of two British directors: GREEN, Simon (appointed 6 December 2021) and SEMIKHODSKII, Andrei, Dr (appointed 6 December 2021). The company has been served by two former officers who have since resigned. Two people with significant control are recorded as having ceased.

Its regulatory record is clean, with no charges, no insolvency proceedings and no liquidation history. The company filed its most recent micro-entity accounts, covering the period to 31 August 2025, on 18 May 2026. The next accounts are due by 31 May 2027. Its most recent confirmation statement was made up to 22 December 2025. The next is due by 5 January 2027. 25 filings are recorded against the company at Companies House, most recently an accounts filing on 18 May 2026.